Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Inventory Average (2016 - 2025)

Historic Inventory Average for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $21.9 million.

  • Harvard Bioscience's Inventory Average fell 1420.38% to $21.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.9 million, marking a year-over-year decrease of 1420.38%. This contributed to the annual value of $24.0 million for FY2024, which is 624.38% down from last year.
  • As of Q3 2025, Harvard Bioscience's Inventory Average stood at $21.9 million, which was down 1420.38% from $22.5 million recorded in Q2 2025.
  • Harvard Bioscience's 5-year Inventory Average high stood at $29.0 million for Q2 2022, and its period low was $21.9 million during Q3 2025.
  • For the 5-year period, Harvard Bioscience's Inventory Average averaged around $25.3 million, with its median value being $25.3 million (2021).
  • In the last 5 years, Harvard Bioscience's Inventory Average skyrocketed by 2527.93% in 2022 and then plummeted by 1420.38% in 2025.
  • Harvard Bioscience's Inventory Average (Quarter) stood at $26.8 million in 2021, then fell by 1.89% to $26.3 million in 2022, then decreased by 3.85% to $25.3 million in 2023, then dropped by 2.57% to $24.6 million in 2024, then fell by 10.92% to $21.9 million in 2025.
  • Its Inventory Average stands at $21.9 million for Q3 2025, versus $22.5 million for Q2 2025 and $23.0 million for Q1 2025.